Total Payments
$6,788
2024 Payments
$2,109
Companies
19
Transactions
66
Medicare Patients
912
Medicare Billing
$79,169
Payment Breakdown by Category
Food & Beverage$3,515 (51.8%)
Consulting$1,760 (25.9%)
Other$1,390 (20.5%)
Education$123.31 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,515 | 61 | 51.8% |
| Consulting Fee | $1,760 | 1 | 25.9% |
| Honoraria | $1,390 | 1 | 20.5% |
| Education | $123.31 | 3 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech, Inc. | $1,783 | 2 | $0 (2023) |
| Alimera Sciences, Inc. | $1,647 | 4 | $0 (2024) |
| Genentech USA, Inc. | $885.96 | 17 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $848.50 | 11 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $427.48 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $225.71 | 4 | $0 (2019) |
| Alcon Puerto Rico Inc | $168.53 | 3 | $0 (2023) |
| Allergan Inc. | $124.94 | 3 | $0 (2018) |
| Astellas Pharma US Inc | $122.49 | 1 | $0 (2024) |
| AbbVie Inc. | $114.65 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,109 | 16 | Alimera Sciences, Inc. ($1,524) |
| 2023 | $1,085 | 20 | Genentech USA, Inc. ($306.85) |
| 2022 | $2,464 | 11 | Genentech, Inc. ($1,760) |
| 2021 | $233.84 | 3 | Regeneron Healthcare Solutions, Inc. ($117.42) |
| 2019 | $359.23 | 6 | Novartis Pharmaceuticals Corporation ($215.02) |
| 2018 | $290.94 | 7 | Regeneron Healthcare Solutions, Inc. ($124.99) |
| 2017 | $245.63 | 3 | Regeneron Healthcare Solutions, Inc. ($225.81) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/29/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/29/2024 | Genentech USA, Inc. | Susvimo (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/24/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Ophthalmology | ||||||
| 08/24/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $47.34 | General |
| Category: Ophthalmology | ||||||
| 08/21/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/20/2024 | Alimera Sciences, Inc. | ILUVIEN (Drug), YUTIQ | Honoraria | Cash or cash equivalent | $1,390.00 | General |
| Category: treatment of diabetic macular edema in patients who have been previously treated with corticosteroid | ||||||
| 07/16/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $34.38 | General |
| Category: Ophthalmology | ||||||
| 07/15/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/17/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: HIV | ||||||
| 06/06/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Ophthalmology | ||||||
| 05/16/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $122.49 | General |
| Category: Ophthalmology | ||||||
| 03/16/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $51.93 | General |
| Category: Ophthalmology | ||||||
| 03/14/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $134.36 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 02/21/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/12/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $93.22 | General |
| Category: Ophthalmology | ||||||
| 12/09/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $52.74 | General |
| 12/09/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $43.57 | General |
| 12/09/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $18.34 | General |
| 12/01/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/30/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $101.60 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/29/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/25/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $10.81 | General |
| Category: Ophthalmology | ||||||
| 10/19/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $132.49 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/10/2023 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $58.48 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 134 | 239 | $13,793 | $9,297 |
| 2022 | 7 | 210 | 401 | $26,626 | $17,601 |
| 2021 | 9 | 261 | 569 | $39,769 | $28,622 |
| 2020 | 9 | 307 | 541 | $35,117 | $23,648 |
Total Patients
912
Total Services
1,750
Medicare Billing
$79,169
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 35 | 70 | $6,334 | $4,456 | 70.4% |
| 92134 | Imaging of retina | Office | 2023 | 43 | 81 | $3,295 | $2,333 | 70.8% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 21 | 25 | $3,181 | $1,824 | 57.3% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 35 | 63 | $982.93 | $684.32 | 69.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 40 | 94 | $8,566 | $5,481 | 64.0% |
| 67028 | Injection of drug into eye | Office | 2022 | 12 | 50 | $5,734 | $4,164 | 72.6% |
| 92134 | Imaging of retina | Office | 2022 | 53 | 101 | $4,180 | $2,750 | 65.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 23 | 28 | $3,611 | $2,319 | 64.2% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 16 | 16 | $2,442 | $1,516 | 62.1% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 53 | 98 | $1,560 | $1,009 | 64.7% |
| 92250 | Photography of the retina | Office | 2022 | 13 | 14 | $532.67 | $360.93 | 67.8% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 55 | 133 | $12,166 | $8,553 | 70.3% |
| 67028 | Injection of drug into eye | Office | 2021 | 18 | 77 | $8,852 | $6,968 | 78.7% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 55 | 126 | $5,255 | $3,758 | 71.5% |
| J3490 | Unclassified drugs | Office | 2021 | 12 | 40 | $3,600 | $2,724 | 75.7% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 22 | 22 | $3,370 | $2,079 | 61.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 18 | 21 | $2,709 | $1,904 | 70.3% |
| 92202 | Extended examination of eye with drawing of optic nerve and surrounding area (macula) | Office | 2021 | 54 | 123 | $1,852 | $1,290 | 69.7% |
| 92235 | Imaging of blood vessels in back of eye using fluorescein dye | Office | 2021 | 11 | 11 | $1,321 | $960.50 | 72.7% |
| 92250 | Photography of the retina | Office | 2021 | 16 | 16 | $645.62 | $385.94 | 59.8% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 69 | 152 | $13,724 | $9,261 | 67.5% |
| 67028 | Injection of drug into eye | Office | 2020 | 11 | 54 | $5,558 | $4,297 | 77.3% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 63 | 123 | $5,114 | $3,603 | 70.5% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 27 | 27 | $4,141 | $1,786 | 43.1% |
| 92235 | Imaging of blood vessels in back of eye using fluorescein dye | Office | 2020 | 21 | 21 | $2,234 | $1,705 | 76.3% |
About Dr. Gabriel Benitez Bajandas, M.D
Dr. Gabriel Benitez Bajandas, M.D is a Ophthalmology healthcare provider based in Humacao, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1821282021.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gabriel Benitez Bajandas, M.D has received a total of $6,788 in payments from pharmaceutical and medical device companies, with $2,109 received in 2024. These payments were reported across 66 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,515).
As a Medicare-enrolled provider, Benitez Bajandas has provided services to 912 Medicare beneficiaries, totaling 1,750 services with total Medicare billing of $79,169. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Humacao, PR
- Active Since 08/30/2007
- Last Updated 03/07/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1821282021
Products in Payments
- Lucentis (Biological) $1,783
- ILUVIEN (Drug) $1,513
- VABYSMO (Drug) $486.00
- Vabysmo (Drug) $376.84
- EYLEA AFLIBERCEPT INJECTION (Biological) $350.80
- EYLEA (Biological) $320.97
- Syfovre (Drug) $298.41
- Clareon (Device) $196.74
- EYLEA HD (Biological) $176.73
- YUTIQ (Drug) $158.83
- Izervay (Drug) $122.49
- BEOVU (Drug) $103.69
- OZURDEX (Drug) $103.38
- INVOKANA (Drug) $93.32
- ACTHAR (Biological) $92.99
- OMNI SURGICAL SYSTEM (Device) $47.34
- VYZULTA (Drug) $30.32
- LOTEMAX (Drug) $27.17
- APRETUDE (Biological) $26.87
- XIIDRA (Drug) $25.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.